Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer based in Jerusalem, Israel, for the month of October 2018. The filing date is October 2, 2018. The report consists solely of a press release incorporated by reference regarding corporate governance changes.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate announcement and does not contain financial statements or performance data.
Material Changes
The material change disclosed in this filing is the appointment of two new external independent members to the Company's Board of Directors. No financial or operational changes were reported in this specific document.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The content is limited to the announcement of the board appointments.
Key Facts for Investor Verification
- Entera Bio Ltd. appointed two new external independent directors to its Board of Directors on October 2, 2018.
- The filing is a Form 6-K reporting a press release and contains no financial data.
- Dr. Phillip Schwartz, Chief Executive Officer, signed the report on behalf of the registrant.